Vertex Pharmaceuticals – Independent Medical Education Grant
Acute Pain RFP 2025/2026 (U.S.)
Vertex Pharmaceuticals Incorporated is seeking proposals for its Independent Medical Education (IME) Grant Opportunity focused on Acute Pain. This competitive RFP supports high-quality, accredited, independent medical education designed to address unmet educational needs and improve patient outcomes—particularly through opioid-sparing approaches to acute pain management.
Organization
Vertex Pharmaceuticals Incorporated
Grant Name
Independent Medical Education Grant Opportunity – Acute Pain RFP 2025/2026
Support Type
Independent Medical Education (IME) Program Grants
Therapeutic Area
Acute Pain
Geographic Focus
United States
Key Dates
📅 RFP Release: December 2025
⏰ Submission Deadline: April 1, 2026 at 5:00 PM ET
⚠️ Requests submitted after the deadline will not be considered for this specific RFP (though they may be eligible under Vertex’s general grants criteria).
About the Funder
Vertex Pharmaceuticals is committed to advancing innovative, science-driven education that is independent, balanced, and free from commercial bias. Through its IME program, Vertex supports educational activities for healthcare professionals that are designed to close knowledge gaps, improve clinical decision-making, and ultimately enhance patient care.
Educational Rationale & Focus
Evidence shows that the risk of chronic opioid use increases with longer initial opioid prescriptions—particularly beyond 3–7 days. This RFP prioritizes education that improves awareness and adoption of non-opioid and opioid-sparing strategies for managing acute moderate-to-severe pain in adults.
Priority topics include:
- Mechanism of action of NaV1.8 voltage-gated sodium channel inhibitors
- Lack of addiction potential associated with NaV1.8 inhibitors
- Incorporating NaV1.8 inhibitors into opioid-sparing analgesic approaches
- Using NaV1.8 inhibitors to minimize the need for opioid prescriptions in acute pain settings
Areas of Interest & Educational Objectives
1. Acute Pain Management
- Opioid-sparing standards of care
- Unmet needs in current acute pain therapeutic options
2. Pain Physiology
- Pain pathophysiology and transmission
- Role of NaV1.7, NaV1.8, and NaV1.9 channels in peripheral-to-central pain signaling
Eligible Educational Formats
Accredited, enduring educational activities and materials, including but not limited to:
- Didactic lectures
- Case-based discussions
- Panel discussions
- Case studies
All activities must comply with applicable accreditation standards and industry regulations.
Target Audience
Healthcare professionals who manage acute pain, including those in:
- Emergency Medicine
- Internal Medicine / Family Medicine
- General Surgery
- Orthopedic Surgery
- Plastic Surgery
- Gynecology
- Urology
Funding Amounts
💰 Requests up to $350,000 will be considered
- Awards may be less than the amount requested
- Applicants are encouraged to seek multiple funding sources
Submission Requirements (Summary)
Proposals must include:
- Comprehensive gap analysis and needs assessment
- Clearly defined learning objectives
- Description of target audience and recruitment strategy
- Evidence-based content plan and accuracy safeguards
- Instructional design aligned with adult learning principles
- Faculty qualifications and development plan
- Evaluation strategy and outcomes measurement
- Detailed, compliant budget (with final reconciliation required)
- Accreditation documentation and COI management plan
- Reporting plan (6-month reports for enduring materials + final outcomes report)
Program Title Requirement:
Program titles must begin with:
“Acute Pain RFP 2025: [Title of Activity]”
Review & Notification
- All requests are reviewed after the submission deadline
- Applicants will be notified by email
- Vertex may request additional information during review
- Funding is not guaranteed and prior support does not ensure approval
- No retroactive funding for activities already completed
Application / Learn More
➡️ Submit through the Vertex Request Management System:
https://www.cybergrants.com/vertexpharmaceuticals/quiz
📧 Questions: vertex_grants@vrtx.com
Use subject line: “Acute Pain RFP 2025/2026”
Why This Opportunity Is a Good Fit
This RFP is a strong match for organizations that:
- Are accredited CME/CE providers
- Design rigorous, independent medical education
- Focus on opioid-sparing strategies and pain science
- Serve U.S.-based clinicians managing acute pain
- Can demonstrate measurable educational and practice impact
Vertex’s Acute Pain IME RFP is particularly well suited for education providers ready to advance evidence-based, non-opioid pain management and improve outcomes across high-impact clinical settings.
Corporate Grants Guide Notes
Review Type: Competitive RFP
Deadline: April 1, 2026 (5:00 PM ET)
Max Request: $350,000
Best Suited For: Accredited medical education providers focused on acute pain and opioid-sparing care
